In silico regulatory analysis for exploring human disease progression

Biology Direct

Volumn 3, Issue , 2008, Pages

  Holloway, Dustin T ^a   Kon, Mark ^b   DeLisi, Charles ^a  

^a BOSTON UNIVERSITY   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; WT1 PROTEIN;

ARTICLE; BIOLOGICAL MODEL; BIOSYNTHESIS; CHILD; CLASSIFICATION; COMPARATIVE STUDY; COMPUTER SIMULATION; DISEASE COURSE; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; HUMAN; METABOLISM; NEPHROBLASTOMA; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; PROTEIN BINDING; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

CHILD; CHILD, PRESCHOOL; COMPUTER SIMULATION; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE TARGETING; GENES, WILMS TUMOR; HUMANS; MODELS, GENETIC; OCTAMER TRANSCRIPTION FACTOR-3; PREDICTIVE VALUE OF TESTS; PROTEIN BINDING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; WILMS TUMOR; WT1 PROTEINS;

EID: 47949090070     PISSN: None     EISSN: 17456150     Source Type: Journal    
DOI: 10.1186/1745-6150-3-24     Document Type: Article

References (232)

1. van Helden J Collado-Vides J Extracting Regulatory Sites from the Upstream Region of Yeast Genes by Computational Analysis of Oligonucleotide Frequencies Journal of Molecular Biology 1998, 281:827-842. 9719638
2. Cawley S Bekiranov S Ng HH Kapranov P Sekinger EA Kampa D Piccolboni A Sementchenko V Cheng J Williams AJ Wheeler R Wong B Drenkow J Yamanaka M Patel S Brubaker S Tammana H Helt G Struhl K Gingeras TR Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs Cell 2004, 116:499-509. 14980218
3. Impey S McCorkle SR Cha-Molstad H Dwyer JM Yochum GS Boss JM McWeeney S Dunn JJ Mandel G Goodman RH Defining the CREB Regulon: A Genome-Wide Analysis of Transcription Factor Regulatory Regions Cell 2004, 119:1041-1054. 15620361
4. Testa A Donati G Yan P Romani F Huang TH Vigano MA Mantovani R Chromatin immunoprecipitation (ChIP) on chip experiments uncover a widespread distribution of NF-Y binding CCAAT sites outside of core promoters J Biol Chem 2005, 280:13606-15. 15647281
5. Stormo GD DNA Binding Sites: Representation and Discovery Bioinformatics 2000, 16:16-23. 10812473
6. Workman CT Stormo GD ANN-Spec: A method for discovering transcription factor binding sites with improved specificity Pac Symp Biocomput 2000, 467-78. 10902194
7. Schneider TD Stormo GD Gold L Ehrenfeucht A Information content of binding sites on nucleotide sequences Journal of Molecular Biology 1986, 188:415-431. 3525846
8. Schneider T Stephens R Sequence logos: A new way to display consensus sequences Nucleic Acids Res 1990, 18:6097-6100. 332411 2172928
9. Fickett JW Coordinate Positioning of MEF2 and Myogenin Binding Sites Gene 1996, 172(1):19-32.
10. Holloway D Kon M DeLisi C Integrating genomic data to predict transcription factor binding Genome Informatics 2005, 16:83-94. 16362910
11. Holloway D Kon M DeLisi C Machine Learning Methods for Transcription Data Integration IBM Journal of Research and Development on Systems Biology 2006, 50.
12. Holloway D Kon M DeLisi C Machine Learning for Regulatory Analysis and Transcription Factor Target Prediction in Yeast Systems and Synthetic Biology 2007, 1:25-46.
13. Holloway DT Kon M DeLisi C Classifying transcription factor targets and discovering relevant biological features Biology Direct 2008, 3:22. 2441612 18513408
14. Karolchik D Baertsch R Diekhans M Furey TS Hinrichs A Lu YT Roskin KM Schwartz M Sugnet CW Thomas DJ Weber RJ Haussler D Kent WJ The UCSC Genome Browser Database Nucl Acids Res 2003, 31:51-54. 165576 12519945
15. Karolchik D Hinrichs AS Furey TS Roskin KM Sugnet CW Haussler D Kent WJ The UCSC Table Browser data retrieval tool Nucleic Acids Res 2004, 32:D493-496. 308837 14681465
16. Guyon I Weston J Barnhill S Vapnik V Gene Selection for Cancer Classification using Support Vector Machines Machine Learning 2002, 46:389-422.
17. Jaakola T Diekhans M Haussler D Using the Fisher kernel method to detect remote protein homologies Proc Int Conf INtell Syst Mol Biol 1999, 149:58. 10786297
18. Hua A novel method of protein secondary structure prediction with high segment overlap measure:sUpport vector machine approach Journal of Molecular Biology 2001, 308:397-407. 11327775
19. Sun Hua Support vector machine approach for protein subcellular localization prediction Bioinformatics 2001, 18:721-728.
20. Zien A Ratsch G Mika S Scholkopf B Lengauer T Muller K-R Engineering support vector machine kernels that recognize translation initiation sites Bioinformatics 2000, 16:799-807. 11108702
21. Wang M Yang J Chou K-C Using string kernel to predict signal peptide cleavage site based on subsite coupling model Amino Acids 2005, 28:395-402. 15838592
22. Furey TS Cristianini N Duffy N Bednarski DW Schummer M Haussler D Support vector machine classification and validation of cancer tissue samples using microarray expression data Bioinformatics 2000, 16:906-914. 11120680
23. Pavlidis P Noble WS Gene Functional Classification from Heterogeneous Data RECOMB Conference Proceedings 2001, 249-255.
24. Platt JC Probabilistic Outputs for Support Vector Machines and Comparisons to Regularized Likelihood Methods Advances in Large Margin Classifiers MIT Press 1999.
25. Naamane N van Helden J Eizirik D In silico identification of NF-kappaB-regulated genes in pancreatic beta-cells BMC Bioinformatics 2007, 8:55. 1810323 17302974
26. Dobson RJ Munroe PB Caulfield MJ Saqi MA Predicting deleterious nsSNPs: an analysis of sequence and structural attributes BMC Bioinformatics 2006, 7:217. 1489951 16630345
27. Bond GL Hu W Bond EE Robins H Lutzker SG Arva NC Bargonetti J Bartel F Taubert H Wuerl P Onel K Yip L Hwang SJ Strong LC Lozano G Levine AJ A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans Cell 2004, 119:591-602. 15550242
28. Das D Nahle Z Zhang MQ Adaptively inferring human transcriptional subnetworks Molecular Systems Biology 2006, 2:2006-2029. 1681499 16760900
29. Friedman JH Roosen CB An introduction to multivariate adaptive regression splines Stat Methods Med Res 1995, 4:197-217. 8548103
30. TFSVM http://cagt10.bu.edu/TFSVM/main.htm
31. Chambers I The molecular basis of pluripotency in mouse embryonic stem cells Cloning And Stem Cells 2004, 6(4):386-391.
32. Boyer LA Tong IL Cole MF Johnstone SE Levine SS Zucker JP Guenther MG Kumar RM Murray HL Jenner RG Gifford DK Melton DA Jaenisch R Young RA Core transcriptional regulatory circuitry in human embryonic stem cells Cell 2005, 122:947-956. 16153702
33. Dennis GJ Sherman BT Hosack DA Yang J Gao W Lane CH Lempicki R DAVID: Database for Annotation, Visualization, and Integrated Discovery Genome Biol 2003, 4:5.
34. Sato N Meijer L Skaltsounis L Greengard P Brivanlou AH Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor 2004, 10:55-63. 14702635
35. Sato N Meijer L Skaltsounis L Greengard P Brivanlou AH Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor Nature Medicine 2004, 10:55-63. 14702635
36. Matin MM Walsh JR Gokhale PJ Draper JS Bahrami AR Morton I Moore HD Andrews PW Specific Knockdown of Oct4 and {beta}2-microglobulin Expression by RNA Interference in Human Embryonic Stem Cells and Embryonic Carcinoma Cells Stem Cells 2004, 22:659-668. 15342930
37. Fajans SS Bell GI Polonsky KS Molecular Mechanisms and Clinical Pathophysiology of Maturity-Onset Diabetes of the Young N Engl J Med 2001, 345:971-980. 11575290
38. Malecki MT Jhala US Antonellis A Fields L Doria A Orban T Saad M Warram JH Montminy M Krolewski AS Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus 1999, 23:323-328. 10545951
39. Luo X Reddy J Yeyati P Idris A Hosono S Haber D Licht J Atweh G The tumor suppressor gene WT1 inhibits ras-mediated transformation Oncogene 1995, 11:743-750. 7651738
40. Haber D Park S Maheswaran S Englert C Re G Hazen-Martin D Sens D Garvin A WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant Science 1993, 262:2057-2059. 8266105
41. Mayo M Wang C Drouin S Madrid L Marshall A Reed J Weissman B Baldwin A WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene EMBO J 1999, 18(14):3990-4003. 1171475 10406804
42. Haber DA Sohn RL Buckler AJ Pelletier J Call KM Housman DE Alternative splicing and genomic structure of the Wilms tumor gene WT1 Proc Natl Acad Sci USA 1991, 88:9618-22. 52769 1658787
43. Wang ZY Qiu QQ Huang J Gurrieri M Deuel TF Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways Oncogene 1995, 10:415-22. 7845666
44. Madden SL Cook DM Morris JF Gashler A Sukhatme VP Rauscher FJ III Transcriptional repression mediated by the WT1 Wilms tumor gene product Science 1991, 253:1550-3. 1654597
45. Rauscher F Morris J Tournay O Cook D Curran T Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence Science 1990, 250:1259-1262. 2244209
46. Sharma PM Bowman M Madden SL Rauscher FJ 3rd Sukumar S RNA editing in the Wilms' tumor susceptibility gene, WT1 Genes Dev 1994, 8:720-31. 7926762
47. Bruening W Pelletier J A non-AUG translational initiation event generates novel WT1 isoforms J Biol Chem 1996, 271:8646-54. 8621495
48. Scharnhorst V Dekker P Eb van der AJ Jochemsen AG Internal translation initiation generates novel WT1 protein isoforms with distinct biological properties J Biol Chem 1999, 274:23456-62. 10438524
49. Ye Y Raychaudhuri B Gurney A Campbell CE Williams BR Regulation of WT1 by phosphorylation: Inhibition of DNA binding, alteration of transcriptional activity and cellular translocation EMBO J 1996, 15:5606-15. 452305 8896454
50. Sakamoto Y Yoshida M Semba K Hunter T Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain Oncogene 1997, 15:2001-12. 9366517
51. Reddy JC Morris JC Wang J English MA Haber DA Shi Y Licht JD WT1-mediated transcriptional activation is inhibited by dominant negative mutant proteins J Biol Chem 1995, 270:10878-84. 7738027
52. Moffett P Bruening W Nakagama H Bardeesy N Housman D Housman DE Pelletier J Antagonism of WT1 activity by protein self-association Proc Natl Acad Sci USA 1995, 92:11105-9. 40580 7479946
53. Englert C Vidal M Maheswaran S Ge Y Ezzell RM Isselbacher KJ Haber DA Truncated WT1 mutants alter the subnuclear localization of the wild-type protein Proc Natl Acad Sci USA 1995, 92:11960-4. 40275 8618823
54. Kim JM Hong Y Semba K Kim S Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1 Biochem Biophys Res Commun 2000, 267:59-63. 10623574
55. Maheswaran S Park S Bernard A Morris JF Rauscher FJ 3rd Hill DE Haber DA Physical and functional interaction between WT1 and p53 proteins Proc Natl Acad Sci USA 1993, 90:5100-4. 46662 8389468
56. Maheswaran S Englert C Bennett P Heinrich G Haber DA The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis Genes Dev 1995, 9:2143-56. 7657166
57. Maheswaran S Englert C Lee SB Ezzel RM Settleman J Haber DA E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells Oncogene 1998, 16:2041-50. 9572485
58. Maheswaran S Englert C Zheng G Lee SB Wong J Harkin DP Bean J Ezzell R Garvin AJ McCluskey RT DeCaprio JA Haber DA Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70 Genes Dev 1998, 12:1108-20. 316709 9553041
59. Brown KW Malik KT The molecular biology of Wilms' tumor Expert Reviews in Molecular Medicine 2001 http://www.expertreviews.org/01003027h.htm 14987361
60. Lee BS Haber D Wilms Tumor and the WT1 Gene Experimental Cell Research 2001, 264:74-79. 11237525
61. Li C-M Kim CE Margolin AA Guo M Zhu J Mason JM Hensle TW Murty VVVS Grundy PE Fearon ER D'Agati V Licht JD Tycko B CTNNB1 Mutations and Overexpression of Wnt/{beta}-Catenin Target Genes in WT1-Mutant Wilms' Tumors Am J Pathol 2004, 165(6):1943-1953. 1618727 15579438
62. Wang ZY Qiu QQ Deuel TF The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains J Biol Chem 1993. 268:9172-5. 8486616
63. Wang ZY Madden SL Deuel TF Rauscher FJ 3rd The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene J Biol Chem 1992, 267:21999-2002. 1429549
64. Gashler AL Bonthron DT Madden SL Rauscher FJ 3rd Collins T Sukhatme VP Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1 Proc Natl Acad Sci USA 1992, 89:10984-8. 50467 1332065
65. Englert C Hou X Maheswaran S Bennett P Ngwu C Re GG Garvin AJ Rosner MR Haber DA WT1 suppresses synthesis of the epidermal growth factor receptor and induces apoptosis EMBO J 1995, 14:4662-75. 394563 7588596
66. Drummond IA Madden SL Rohwer-Nutter P Bell GI Sukhatme VP Rauscher FJ 3rd Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1 Science 1992, 257:674-8. 1323141
67. Werner H Re GG Drummond IA Sukhatme VP Rauscher FJ 3rd Sens DA Garvin AJ LeRoith D Roberts CT Jr Increased expression of the insulin-like growth factor I receptor gene, IGF1R, in Wilms tumor is correlated with modulation of IGF1R promoter activity by the WT1 Wilms tumor gene product Proc Natl Acad Sci USA 1993, 90:5828-32. 46816 8390684
68. Werner H Shen-Orr Z Rauscher FJ 3rd Morris JF Roberts CT Jr LeRoith D Inhibition of cellular proliferation by the Wilms' tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression Mol Cell Biol 1995, 15:3516-22. 230588 7791758
69. Adachi Y Matsubara S Pedraza C Ozawa M Tsutsui J Takamatsu H Noguchi H Akiyama T Muramatsu T Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1) Oncogene 1996, 13:2197-203. 8950987
70. Hewitt SM Hamada S McDonnell TJ Rauscher FJ 3rd Saunders GF Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1 Cancer Res 1995, 55:5386-9. 7585606
71. Zhang X Xing G Saunders GF Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1 Anticancer Res 1999, 19:1641-8. 10470095
72. Rupprecht HD Drummond IA Madden SL Rauscher FJ 3rd Sukhatme VP The Wilms' tumor suppressor gene WT1 is negatively autoregulated J Biol Chem 1994, 269:6198-206. 8119964
73. Malik KT Poirier V Ivins SM Brown KW Autoregulation of the human WT1 gene promoter FEBS Letters 1994, 349:75-8. 8045305
74. Hewitt SM Fraizer GC Wu Y-J Rauscher FJ III Saunders GF Differential Function of Wilms' Tumor Gene WT1 Splice Isoforms in Transcriptional Regulation J Biol Chem 1996, 271:8588-8592. 8621487
75. Ryan G Steele-Perkins V Morris JF Rauscher FJ 3rd Dressler GR Repression of Pax-2 by WT1 during normal kidney development Development 1995, 121:867-75. 7720589
76. Dey BR Sukhatme VP Roberts AB Sporn MB Rauscher FJ 3rd Kim SJ Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product Mol Endocrinol 1994, 8:595-602. 8058069
77. Goodyer P Dehbi M Torban E Bruening W Pelletier J Repression of the retinoic acid receptor-alpha gene by the Wilms' tumor suppressor gene product, wt1 Oncogene 1995, 10:1125-9. 7700638
78. McCoy C McGee SB Cornwell MM The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter Cell Growth Differ 1999, 10:377-86. 10392899
79. Martinerie C Chevalier G Rauscher FJ 3rd Perbal B Regulation of nov by WT1: A potential role for nov in nephrogenesis Oncogene 1996, 12:1479-92. 8622864
80. Shimamura R Fraizer GC Trapman J Lau Yf C Saunders GF The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Mullerian-inhibiting substance, and the androgen receptor Clin Cancer Res 1997, 3:2571-80. 9815658
81. Kinane TB Finder JD Kawashima A Brown D Abbate M Fredericks WJ Sukhatme VP Rauscher FJ 3rd Ercolani L LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription J Biol Chem 1995, 270:30760-4. 8530517
82. Stanhope-Baker P Williams BR Identification of connective tissue growth factor as a target of WT1 transcriptional regulation J Biol Chem 2000, 275:38139-50. 10973960
83. English MA Licht JD Tumor-associated WT1 missense mutants indicate that transcriptional activation by WT1 is critical for growth control J Biol Chem 1999, 274:13258-63. 10224085
84. Englert C Maheswaran S Garvin AJ Kreidberg J Haber DA Induction of p21 by the Wilms' tumor suppressor gene WT1 Cancer Res 1997, 57:1429-34. 9108440
85. Lee SB Huang K Palmer R Truong VB Herzlinger D Kolquist KA Wong J Paulding C Yoon SK Gerald W Oliner JD Haber DA The Wilms tumor suppressor WT1 encodes a transcriptional activator of amphiregulin Cell 1999, 98:663-73. 10490105
86. Cook DM Hinkes MT Bernfield M Rauscher FJ 3rd Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1 Oncogene 1996, 13:1789-99. 8895526
87. Hosono S Gross I English MA Hajra KM Fearon ER Licht JD E-cadherin is a WT1 target gene J Biol Chem 2000, 275:10943-53. 10753894
88. Mayo MW Wang CY Drouin SS Madrid LV Marshall AF Reed JC Weissman BE Baldwin AS WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene EMBO J 1999, 18:3990-4003. 1171475 10406804
89. Heckman C Mochon E Arcinas M Boxer LM The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomas J Biol Chem 1997, 272:19609-14. 9235968
90. Kim J Prawitt D Bardeesy N Torban E Vicaner C Goodyer P Zabel B Pelletier J The Wilms' tumor suppressor gene (wt1) product regulates Dax-1 gene expression during gonadal differentiation Mol Cell Biol 1999, 19:2289-99. 84021 10022915
91. Nachtigal MW Hirokawa Y Enyeart-VanHouten DL Flanagan JN Hammer GD Ingraham HA Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression Cell 1998, 93:445-54. 9590178
92. Harrington MA Konicek B Song A Xia XL Fredericks WJ Rauscher FJ 3rd Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms' tumor locus J Biol Chem 1993, 268:21271-5. 8407965
93. Thate C Englert C Gessler M Analysis of WT1 target gene expression in stably transfected cell lines Oncogene 1998, 17:1287-94. 9771972
94. Guan LS Li GC Chen CC Liu LQ Wang ZY Rb-associated protein 46 (RbAp46) suppresses the tumorigenicity of adenovirus-transformed human embryonic kidney 293 cells Int J Cancer 2001, 93:333-8. 11433396
95. Maurer U Jehan F Englert C Hubinger G Weidmann E DeLuca HF Bergmann L The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor J Biol Chem 2001, 276:3727-32. 11050081
96. Li RS Law GL Seifert RA Romaniuk PJ Morris DR Ornithine decarboxylase is a transcriptional target of tumor suppressor WT1 Exp Cell Res 1999, 247:257-66. 10047468
97. Pelletier J Bruening W Li FP Haber DA Glaser T Housman DE WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour Nature 1991, 353:431-4. 1654525
98. Bruening W Bardeesy N Silverman BL Cohn RA Machin GA Aronson AJ Housman D Pelletier J Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development Nat Genet 1992, 1:144-8. 1302008
99. Armstrong JF Pritchard-Jones K Bickmore WA Hastie ND Bard JB The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo Mechanisms of Development 1993, 40:85-97. 8382938
100. Rackley RR Flenniken AM Kuriyan NP Kessler PM Stoler MH Williams BR Expression of the Wilms' tumor suppressor gene WT1 during mouse embryogenesis Cell Growth Differ 1993, 4(12):1023-31. 8117616
101. Bard JB McConnell JE Davies JA Towards a genetic basis for kidney development Mechanisms of Development 1994, 48:3-11. 7833287
102. Inoue K Sugiyama H Ogawa H Nakagawa M Yamagami T Miwa H Kita K Hiraoka A Masaoka T Nasu K WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia Blood 1994, 84:3071-3079. 7949179
103. Oji Y Miyoshi S Maeda H Hayashi S Tamaki H Nakatsuka S-I Yao M Takahashi E Nakano Y Hirabayashi H Shintani Y Oka Y Tsuboi A Hosen N Asada M Fujioka T Murakami M Kanato K Motomura M Kim EH Kawakami M Ikegame K Ogawa H Aozasa K Kawase I Sugiyama H Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers International Journal of Cancer 2002, 100:297-303.
104. Oji Y Yamamoto H Nomura M Nakano Y Ikeba A Nakatsuka S-i Abeno S Kiyotoh E Jomgeow T Sekimoto M Nezu R Yoshikawa Y Inoue Y Hosen N Kawakami M Tsuboi A Oka Y Ogawa H Souda S Aozasa K Monden M Sugiyama H Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma Cancer Science 2003, 94:712-717. 12901797
105. Oji Y Miyoshi Y Koga S Nakano Y Ando A Nakatsuka S-i Ikeba A Takahashi E Sakaguchi N Yokota A Hosen N Ikegame K Kawakami M Tsuboi A Oka Y Ogawa H Aozasa K Noguchi S Sugiyama H Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer Cancer Science 2003, 94:606-611. 12841869
106. Loeb DM Evron E Patel CB Sharma PM Niranjan B Buluwela L Weitzman SA Korz D Sukumar S Wilms' Tumor Suppressor Gene (WT1) Is Expressed in Primary Breast Tumors Despite Tumor-specific Promoter Methylation Cancer Res 2001, 61:921-925. 11221883
107. Oji Y Yano M Nakano Y Abeno S Nakatsuka S-i Ikeba A Yasuda T Fujiwara Y Takiguchi S Yamamoto H Fujita S Kanato K Ito K Jomgeow T Kawakami M Tsuboi A Shirakata T Nishida S Hosen N Oka Y Aozasa K Monden M Sugiyama H Overexpression of the Wilms' tumor gene WT1 in esophageal cancer Anticancer Research 2004, 24:3103-3108. 15510596
108. Oji Y Nakamori S Fujikawa M Nakatsuka S-i Yokota A Tatsumi N Abeno S Ikeba A Takashima S Tsujie M Yamamoto H Sakon M Nezu R Kawano K Nishida S Ikegame K Kawakami M Tsuboi A Oka Y Yoshikawa K Aozasa K Monden M Sugiyama H Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma Cancer Science 2004, 95:583-587. 15245594
109. Oji Y Inohara H Nakazawa M Nakano Y Akahani S Nakatsuka S-i Koga S Ikeba A Abeno S Honjo Y Yamamoto Y Iwai S Yoshida K Oka Y Ogawa H Yoshida J-i Aozasa K Kubo T Sugiyama H Overexpression of the Wilms' tumor gene WT1 in head and neck squamous cell carcinoma Cancer Science 2003, 94:523-529. 12824878
110. Ueda T Oji Y Naka N Nakano Y Takahashi E Koga S Asada M Ikeba A Nakatsuka S-i Abeno S Hosen N Tomita Y Aozasa K Tamai N Myoui A Yoshikawa H Sugiyama H Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas Cancer Science 2003, 94:271-276. 12824921
111. Oji Y Suzuki T Nakano Y Maruno M Nakatsuka S-i Jomgeow T Abeno S Tatsumi N Yokota A Aoyagi S Nakazawa T Ito K Kanato K Shirakata T Nishida S Hosen N Kawakami M Tsuboi A Oka Y Aozasa K Yoshimine T Sugiyama H Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors Cancer Science 2004, 95:822-827. 15504250
112. Haber DA Buckler AJ Glaser T Call KM Pelletier J Sohn RL Douglass EC Housman DE An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor Cell 1990, 61:1257-69. 2163761
113. Cowell JK Wadey RB Haber DA Call KM Housman DE Pritchard J Structural rearrangements of the WT1 gene in Wilms' tumour cells Oncogene 1991, 6:595-9. 1851548
114. Coppes MJ Liefers GJ Paul P Yeger H Williams BR Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor Proc Natl Acad Sci USA 1993, 90:1416-9. 45884 8381965
115. Varanasi R Bardeesy N Ghahremani M Petruzzi MJ Nowak N Adam MA Grundy P Shows TB Pelletier J Fine structure analysis of the WT1 gene in sporadic Wilms tumors Proc Natl Acad Sci USA 1994, 91:3554-8. 43618 8170946
116. Knudson AG Jr Strong LC Mutation and cancer: A model for Wilms' tumor of the kidney J Natl Cancer Inst 1972, 48:313-24. 4347033
117. Coppes MJ Liefers GJ Higuchi M Zinn AB Balfe JW Williams BR Inherited WT1 mutation in Denys-Drash syndrome Cancer Research 1992, 52:6125-8. 1327525
118. Coppes MJ Egeler RM Genetics of Wilms' tumor Seminars in Urologic Oncology 1999, 17:2-10. 10073400
119. Coppes MJ Clericuzio CL "Molecular genetic analysis of the WT1 gene in patients suspected to have the Denys-Drash syndrome" Med Pediatric Oncology 1994, 23(4):390.
120. Coppes MJ Huff V Pelletier J Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WT1 J Pediatr 1993, 123(5):673-8. 8229473
121. Little MH Prosser J Condie A Smith PJ Van Heyningen V Hastie ND Zinc finger point mutations within the WT1 gene in Wilms tumor patients Proc Natl Acad Sci USA 1992, 89:4791-5. 49173 1317572
122. Coppes MJ Liefers GJ Paul P Yeger H Williams BR Homozygous somatic Wt1 point mutations in sporadic unilateral Wilms tumor Proc Natl Acad Sci USA 1993, 90:1416-9. 45884 8381965
123. Yuan E Li CM Yamashiro DJ Kandel J Thaker H Murty VV Tycko B Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors Mol Cancer Res 2005, 3:493-502. 16179496
124. Klamt B Schulze M Thäte C Mares J Goetz P Kodet R Scheurlen W Weirich A Graf N Gessler M Allele loss in Wilms tumors of chromosome arms 11q, 16q, and 22q correlates with clinicopathological parameters Genes, Chromosomes and Cancer 1998, 22:287-294.
125. Grundy PE Telzerow P Breslow N Moksness J Huff V Paterson M Loss of heterozygosity for chromosomes 16q and p1 in Wilms' tumors predicts an adverse outcome Cancer Research 1994, 54:2331-2331. 8162576
126. Ruteshouser C Hendrickson BW Colella S Krahe R Pinto L Huff V Genome-wide loss of heterozygosity analysis of WT1-wild-type and WT1-mutant Wilms tumors Genes Chromosomes Cancer 2005, 43(2):172-180. 15761866
127. Mannens M Slater R Heyting C Bliek J de Kraker J Coad N de Pagter-Holthuizen P Pearson P Molecular nature of genetic changes resulting in loss of heterozygosity of chromosome 11 in Wilms' tumours Human Genetics 1988, 81:41-48. 2848758
128. Satoh Y Nakadate H Nakagawachi T Higashimoto K Joh K Masaki Z Uozumi J Kaneko Y Mukai T Soejima H Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours British Journal of Cancer 2006, 95:541-547. 16909133
129. Satoh Y Nakagawachi T Nakadate H Kaneko Y Masaki Z Mukai T Soejima H Significant Reduction of WT1 Gene Expression, Possibly Due to Epigenetic Alteration in Wilms' Tumor J Biochem 2003, 133(3):303-308. 12761165
130. Fraizer G Leahy R Priyadarshini S Graham K Delacerda J Diaz M Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene Int J Oncol 2004, 24:461-71. 14767530
131. Haber DA Park S Maheswaran S Englert C Re GG Hazen-Martin DJ Sens DA Garvin AJ WT1-mediated growth suppression of Wilms tumor cells expressing a WT1 splicing variant Science 1993, 262:2057-9. 8266105
132. Coppes M Liefers G Paul P Yeger H Williams B Homozygous Somatic WT1 Point Mutations in Sporadic Unilateral Wilms Tumor Proc Natl Acad Sci USA 1993, 90:1416-1419. 45884 8381965
133. Little M Wells C A clinical overview of WT1 gene mutations Human Mutation 1997, 9:209-225. 9090524
134. Srivastava A Fuchs B Zhang K Ruan M Halder C Mahlum E Weber K Bolander ME Sarkar G High WT1 expression is associated with very poor survival of patients with osteogenic sarcoma metastasis Clin Cancer Res 2006, 12:4237-43. 16857797
135. Cilloni D Gottardi E Saglio G WT1 overexpression in acute myeloid leukemia and myelodysplastic syndromes Methods in Molecular Medicine 2006, 125:199-211. 16502587
136. Zheng JY Yang GS Wang WZ Li J Li KZ Guan WX Wang WL Overexpression of Bax induces apoptosis and enhances drug sensitivity of hepatocellular cancer-9204 cells World J Gastroenterol 2005, 11:3498-503. 15962362
137. van Delft MF Huang DC How the Bcl-2 family of proteins interact to regulate apoptosis Cell Res 2006, 16:203-13. 16474435
138. Moon E Lee R Near R Weintraub L Wolda S Lerner A Inhibition of PDE3B Augments PDE4 Inhibitor-induced Apoptosis in a Subset of Patients with Chronic Lymphocytic Leukemia Clin Cancer Res 2002, 8:589-595. 11839681
139. Heyningen V Bickmore W Seawright A Fletcher J Maule J Fekete G Gessler M Bruns G Huerre-Jeanpierre C Junien C Williams B Hastie N Role for the Wilms Tumor Gene in Genital Development Proc Natl Acad Sci USA 1990, 87:5383-5386. 54328 1973540
140. Elliott M Maher E Beckwith-Wiedemann syndrome Journal of Medical Genetics 1994, 31:560-564. 1049980 7966193
141. Call KM Glaser T Ito CY Buckler AJ Pelletier J Haber DA Rose EA Kral A Yeger H Lewis WH Jonese C Housman D Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus Cell 1990, 60:509-20. 2154335
142. Gessler M Poustka A Cavenee W Neve RL Orkin SH Bruns GA Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping Nature 1990, 343:774-8. 2154702
143. Lee SB Haber DA Wilms tumor and the WT1 gene Exp Cell Res 2001, 264:74-99. 11237525
144. Giannoukakis N Deal C Paquette J Goodyer CG Polychronakos C Parental genomic imprinting of the human IGF2 gene Nat Genet 1993, 4:98-101. 8099843
145. Ohlsson R Nystrom A Pfeifer-Ohlsson S Tohonen V Hedborg F Schofield P Flam F Ekstrom TJ IGF2 is parentally imprinted during human embryogenesis and in the Beckwith-Wiedemann syndrome Nat Genet 1993, 4:94-7. 8513333
146. Ogawa O Becroft DM Morison IM Eccles MR Skeen JE Mauger DC Reeve AE Constitutional relaxation of insulin-like growth factor II gene imprinting associated with Wilms' tumour and gigantism Nat Genet 1993, 5:408-12. 8298652
147. Weksberg R Shen DR Fei YL Song QL Squire J Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann syndrome Nat Genet 1993, 5:143-50. 8252039
148. Bartolomei MS Zemel S Tilghman SM Parental imprinting of the mouse H19 gene Nature 1991, 351:153-5. 1709450
149. Engel N West AG Felsenfeld G Bartolomei MS Antagonism between DNA hypermethylation and enhancer-blocking activity at the H19 DMD is uncovered by CpG mutations Nat Genet 2004, 36:883-8. 15273688
150. Verona RI Bartolomei MS Role of H19 3′ sequences in controlling H19 and Igf2 imprinting and expression Genomics 2004, 84:59-68. 15203204
151. Hatada I Inazawa J Abe T Nakayama M Kaneko Y Jinno Y Niikawa N Ohashi H Fukushima Y Iida K Yutani C Takahashi S Chiba Y Ohishi S Mukai T Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors Hum Mol Genet 1996, 5:783-8. 8776593
152. Matsuoka S Thompson JS Edwards MC Bartletta JM Grundy P Kalikin LM Harper JW Elledge SJ Feinberg AP Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15 Proc Natl Acad Sci USA 1996, 93:3026-30. 39755 8610162
153. Eggenschwiler J Ludwig T Fisher P Leighton PA Tilghman SM Efstratiadis A Mouse mutant embryos overexpressing IGF-II exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes Genes Dev 1997, 11:3128-42. 316748 9389646
154. Fu P Chen J Tian Y Watkins T Cui X Zhao B Anti-tumor effect of hematopoietic cells carrying the gene of ribonuclease inhibitor Cancer Gene Ther 2004, 12(3):268-275.
155. Yang J Chen W Liu Z Luo Y Liu W Effects of insulin-like growth factors-IR and -IIR antisense gene transfection on the biological behaviors of SMMC-7721 human hepatoma cells J Gastroenterol Hepatol 2003, 18(3):296-301. 12603530
156. Winterwood NE Varzavand A Meland MN Ashman LK Stipp CS A Critical Role for Tetraspanin CD151 in {alpha}3beta1 and {alpha}6beta4
157. Saur G Kurzeder C Grundmann R Kreienberg R Zeillinger R Deissler H Expression of tetraspanin adaptor proteins below defined threshold values is associated with in vitro invasiveness of mammary carcinoma cells Oncol Rep 2003, 10(2):405-410. 12579280
158. Goldberg M Wei M Tycko B Falikovich I Warburton D Identification and expression analysis of the human mu-protocadherin gene in fetal and adult kidneys Am J Physiol Renal Physiol 2002, 283:F454-63. 12167596
159. Vairaktaris E Ragos V Yapijakis C Derka S Vassiliou S Nkenke E Yannopoulos A Spyridonidou S Vylliotis A Papakosta V Loukeri S Lazaris A Tesseromatis C Tsigris C Patsouris E FGFR-2 and -3 play an important role in initial stages of oral oncogenesis Anticancer Res 2006, 26:4217-21. 17201136
160. Hafner C Vogt T Hartmann A FGFR3 mutations in benign skin tumors Cell Cycle 2006, 5:2723-8. 17172848
161. Hernandez S Lopez-Knowles E Lloreta J Kogevinas M Amoros A Tardon A Carrato A Serra C Malats N Real FX Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas J Clin Oncol 2006, 24:3664-71. 16877735
162. Kumar S Hand PH Marsden HB Kumar P Thor A Quantitation of enhanced expression of ras-oncogene product (p21) in childhood renal tumours Anticancer Res 1991, 11:1657-62. 1660693
163. Goldberg M Wei M Yuan L Murty VV Tycko B Biallelic expression of HRAS and MUCDHL in human and mouse Hum Genet 2003, 112:334-42. 12589428
164. Logie A Dunois-Larde C Rosty C Levrel O Blanche M Ribeiro A Gasc J-M Jorcano J Werner S Sastre-Garau X Thiery JP Radvanyi F Activating mutations of the tyrosine kinase receptor FGFR3 are associated with benign skin tumors in mice and humans Hum Mol Genet 2005, 14:1153-1160. 15772091
165. van Oers JMM Lurkin I van Exsel AJA Nijsen Y van Rhijn BWG Aa van der MNM Zwarthoff EC A Simple and Fast Method for the Simultaneous Detection of Nine Fibroblast Growth Factor Receptor 3 Mutations in Bladder Cancer and Voided Urine Clin Cancer Res 2005, 11:7743-7748. 16278395
166. Kochetkova M McKenzie OLD Bais AJ Martin JM Secker GA Seshadri R Powell JA Hinze SJ Gardner AE Spendlove HE O'Callaghan NJ Cleton-Jansen A-M Cornelisse C Whitmore SA Crawford J Kremmidiotis G Sutherland GR Callen DF CBFA2T3 (MTG16) Is a Putative Breast Tumor Suppressor Gene from the Breast Cancer Loss of Heterozygosity Region at 16q24.3 Cancer Res 2002, 62:4599-4604. 12183414
167. Ejeskar K Krona C Caren H Zaibak F Li L Martinsson T Ioannou P Introduction of in vitro transcribed ENO1 mRNA into neuroblastoma cells induces cell death BMC Cancer 2005, 5:161. 1327688 16359544
168. Astrinidis A Cash TP Hunter DS Walker CL Chernoff J Henske EP Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration Oncogene 2002, 21:8470-6. 12466966
169. Jin F Wienecke R Xiao GH Maize JC Jr DeClue JE Yeung RS Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region Proc Natl Acad Sci USA 1996, 93:9154-9. 38611 8799170
170. Sampson JR TSC1 and TSC2: Genes that are mutated in the human genetic disorder tuberous sclerosis Biochem Soc Trans 2003, 31:592-6. 12773162
171. Merritt JL 2nd Davis DM Pittelkow MR Babovic-Vuksanovic D Extensive acrochordons and pancreatic islet-cell tumors in tuberous sclerosis associated with TSC2 mutations Am J Med Genet A 2006, 140:1669-72. 16835931
172. Knowles MA Hornigold N Pitt E Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours Biochem Soc Trans 2003, 31:597-602. 12773163
173. Ramesh V Aspects of tuberous sclerosis complex (TSC) protein function in the brain Biochem Soc Trans 2003, 31:579-83. 12773159
174. De Schrijver E Brusselmans K Heyns W Verhoeven G Swinnen JV RNA Interference-mediated Silencing of the Fatty Acid Synthase Gene Attenuates Growth and Induces Morphological Changes and Apoptosis of LNCaP Prostate Cancer Cells Cancer Res 2003, 63:3799-3804. 12839976
175. Menendez J Colomer R Lupu R Inhibition of tumor-associated fatty acid synthase activity enhances vinorelbine (Navelbine)-induced cytotoxicity and apoptotic cell death in human breast cancer cells Oncology Reports 2004, 12:411-422. 15254710
176. Perotti D De Vecchi G Testi MA Lualdi E Modena P Mondini P Ravagnani F Collini P Di Renzo F Spreafico F Terenziani M Sozzi G Fossati-Bellani F Radice P Germline mutations of the POU6F2 gene in Wilms tumors with loss of heterozygosity on chromosome 7p14 Human Mutation 2004, 24:400-407. 15459955
177. Hoei-Hansen CE Almstrup K Nielsen JE Brask Sonne S Graem N Skakkebaek NE Leffers H Rajpert-De Meyts E Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours Histopathology 2005, 47:48-56. 15982323
178. Ma X Chen K Huang S Zhang X Adegboyega PA Evers BM Zhang H Xie J Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas Carcinogenesis 2005, 26:1698-1705. 15905200
179. Fridlyand J Snijders A Ylstra B Li H Olshen A Segraves R Dairkee S Tokuyasu T Ljung B Jain A McLennan J Ziegler J Chin K Devries S Feiler H Gray J Walderman F Pinkel D Albertson D Breast tumor copy number aberration phenotypes and genomic instability BMC Cancer 2006, 6. 1459181 16620391
180. Looijenga LHJ Stoop H de Leeuw HPJC de Gouveia Brazao CA Gillis AJM van Roozendaal KEP van Zoelen EJJ Weber RFA Wolffenbuttel KP van Dekken H Honecker F Bokemeyer C Perlman EJ Schneider DT Kononen J Sauter G Oosterhuis JW POU5F1 (OCT3/4) Identifies Cells with Pluripotent Potential in Human Germ Cell Tumors Cancer Res 2003, 63:2244-2250. 12727846
181. Metcalf D Dakic A Mifsud S Di Rago L Wu L Nutt S Inactivation of PU.1 in adult mice leads to the development of myeloid leukemia Proc Natl Acad Sci USA 2006, 103:1486-1491. 1360594 16432184
182. Seligson D Horvath S Huerta-Yepez S Hanna S Garban H Roberts A Shi T Liu X Chia D Goodglick L Bonavida B Expression of transcription factor Yin Yang 1 in prostate cancer International Journal of Oncology 2005, 27:131-141. 15942652
183. Mundschau G Gurbuxani S Gamis AS Greene ME Arceci RJ Crispino JD Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis Blood 2003, 101:4298-4300. 12560215
184. Oya M Horiguchi A Mizuno R Marumo K Murai M Increased Activation of CCAAT/Enhancer Binding Protein-{beta} Correlates with the Invasiveness of Renal Cell Carcinoma Clin Cancer Res 2003, 9:1021-1027. 12631601
185. Hu Z Mellor J Wu J DeLisi C VisANT: An online visualization and analysis tool for biological interaction data BMC Bioinformatics 2004, 5:17. 368431 15028117
186. Hu Z Mellor J Wu J Yamada T Holloway D DeLisi C VisANT: Data-integrating visual framework for biological networks and modules Nucleic Acids Res 2005, 33:W352-357. 1160192 15980487
187. Pan G Thomson JA Nanog and transcriptional networks in embryonic stem cell pluripotency Cell Res 2007, 17:42-9. 17211451
188. Zheng J Kitajima K Sakai E Kimura T Minegishi N Yamamoto M Nakano T Differential effects of GATA-1 on proliferation and differentiation of erythroid lineage cells Blood 2006, 107:520-7. 16174764
189. Fujiwara Y Chang AN Williams AM Orkin SH Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development Blood 2004, 103:583-5. 14504093
190. Cooper SJ Trinklein ND Nguyen L Myers RM Serum response factor binding sites differ in three human cell types Genome Res 2007, 17:136-44. 1781345 17200232
191. Belaguli NS Schildmeyer LA Schwartz RJ Organization and Myogenic Restricted Expression of the Murine Serum Response Factor Gene. A Role for Autoregulation J Biol Chem 1997, 272:18222-18231. 9218459
192. Zhao P Hoffman EP Embryonic myogenesis pathways in muscle regeneration Dev Dyn 2004, 229:380-92. 14745964
193. Iida K Hidaka K Takeuchi M Nakayama M Yutani C Mukai T Morisaki T Expression of MEF2 genes during human cardiac development Tohoku J Exp Med 1999, 187:15-23. 10458488
194. Edmondson DG Lyons GE Martin JF Olson EN Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis Development 1994, 120:1251-63. 8026334
195. Wang J Rao S Chu J Shen X Levasseur DN Theunissen TW Orkin SH A protein interaction network for pluripotency of embryonic stem cells Nature 2006, 444:364-8. 17093407
196. Sun Y Li H Yang H Rao MS Zhan M Mechanisms controlling embryonic stem cell self-renewal and differentiation Crit Rev Eukaryot Gene Expr 2006, 16:211-31. 17073552
197. Ezeh UI Turek PJ Reijo RA Clark AT Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma Cancer 2005, 104:2255-65. 16228988
198. Jones TD Ulbright TM Eble JN Cheng L OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis Clin Cancer Res 2004, 10:8544-7. 15623637
199. Chambers I Smith A Self-renewal of teratocarcinoma and embryonic stem cells Oncogene 2004, 23:7150-60. 15378075
200. Fraizer G Wu Y Hewitt S Maity T Ton C Huff V Saunders G Transcriptional regulation of the human Wilms' tumor gene (WT1). Cell type-specific enhancer and promiscuous promoter J Biol Chem 1994, 269:8892-8900. 8132626
201. Nakagama H Heinrich G Pelletier J Housman D Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product Mol Cell Biol 1995, 15:1489-1498. 230373 7862142
202. van Helden J Regulatory sequence analysis tools Nucleic Acids Res 2003, 31:3593-3596. 168973 12824373
203. Pavesi G Mauri G Pesole G An algorithm for finding signals of unknown length in DNA sequences Bioinformatics 2001, 17:S207-214. 11473011
204. Pavesi G Mereghetti P Mauri G Pesole G Weeder Web: Discovery of transcription factor binding sites in a set of sequences from co-regulated genes Nucleic Acids Res 2004, 32:W199-203. 441603 15215380
205. Pavesi G Mereghetti P Zambelli F Stefani M Mauri G Pesole G MoD Tools: regulatory motif discovery in nucleotide sequences from co-regulated or homologous genes Nucleic Acids Res 2006, 34:W566-570. 1538899 16845071
206. Tompa M Li N Bailey TL Church GM De Moor B Eskin E Favorov AV Frith MC Fu Y Kent WJ Makeev VJ Mironov AA Noble WS Pavesi G Pesole G Regnier M Simonis N Sinha S Thijs G van Helden J Vandenbogaert M Weng Z Workman C Ye C Zhu Z Assessing computational tools for the discovery of transcription factor binding sites Nature Biotechnology 2005, 23:137-144. 15637633
207. Vert J-P Thurman R Noble WS Kernels for Gene Regulatory Regions Proceedings of the 19th Annual Conference on Neural and Information Systems, Vancouver, BC 2005.
208. Vapnik V Statistical Learning Theory Text:THe Nature of Statistical Learning Theory 1998.
209. Holloway D Kon M DeLisi C Machine Learning for Predicting Targets of Transcription Factors in Yeast: Epub at Systems and Synthetic Biology 2006. http://www.springerlink.com/content/73352l0r01424v53/
210. Weston J Elisseeff A Bakir G Sinz F SPIDER, object oriented machine learning library http://www.kyb.tuebingen.mpg.de/bs/people/spider/
211. Chang C-C Lin C-J LIBSVM: A Library for Support Vector Machines http://www.csie.ntu.edu.tw/~cjlin/papers/libsvm.pdf
212. Simonis N Wodak SJ Cohen GN van Helden J Combining pattern discovery and discriminant analysis to predict gene co-regulation Bioinformatics 2004, 20:2370-2379. 15073004
213. Holloway DT Kon M DeLisi C Classifying transcription factor targets and discovering relevant biological features Biology Direct 2008, 3:22. 2441612 18513408
214. Matlab The Mathworks 2006 http://www.mathworks.com/
215. Tan PN Steinbach M Kumar V Introduction to Data Mining Pearson Addison Wesley 2006.
216. Leslie C Eskin E Noble WS The Spectrum Kernel: A string kernel for SVM protein classification Pac Symp Biocomput 2002, 564-575. 11928508
217. Leslie CS Eskin E Cohen A Weston J Noble WS Mismatch string kernels for discriminative protein classification Bioinformatics 2004, 20:467-476. 14990442
218. Leslie C Kuang R Fast kernels for inexact string matching Proceedings of the Conference on Learning Theory and Kernel Workshop 2003.
219. Siepel A Haussler D Combining Phylogenetic and Hidden Markov Models in Biosequence Analysis Journal of Computational Biology 2004, 11:413-428. 15285899
220. Siepel A Bejerano G Pedersen JS Hinrichs AS Hou M Rosenbloom K Clawson H Spieth J Hillier LW Richards S Weinstock GM Wilson RK Gibbs RA Kent WJ Miller W Haussler D Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes Genome Res 2005, 15:1034-1050. 1182216 16024819
221. Montgomery SB Griffith OL Sleumer MC Bergman CM Bilenky M Pleasance ED Prychyna Y Zhang X Jones SJM ORegAnno: An open access database and curation system for literature-derived promoters, transcription factor binding sites and regulatory variation Bioinformatics 2006, 22:637-640. 16397004
222. Kolchanov NA Ignatieva EV Ananko EA Podkolodnaya OA Stepanenko IL Merkulova TI Pozdnyakov MA Podkolodny NL Naumochkin AN Romashchenko AG Transcription Regulatory Regions Database (TRDD): Its status in 2002 Nucleic Acids Res 2002, 30:312-317. 99088 11752324
223. Matys V Kel-Margoulis OV Fricke E Liebich I Land S Barre-Dirrie A Reuter I Chekmenev D Krull M Hornischer K Voss N Stegmaier P Lewicki-Potapov B Saxel H Kel AE Wingender E TRANSFAC(R) and its module TRANSCompel(R): transcriptional gene regulation in eukaryotes Nucleic Acids Res 2006, 34:D108-110. 1347505 16381825
224. Birney E Andrews D Caccamo M Chen Y Clarke L Coates G Cox T Cunningham F Curwen V Cutts T Down T Durbin R Fernandez-Suarez XM Flicek P Graf S Hammond M Herrero J Howe K Iyer V Jekosch K Kahari A Kasprzyk A Keefe D Kokocinski F Kulesha E London D Longden I Melsopp C Meidl P Overduin B et al. Ensembl 2006 Nucleic Acids Res 2006, 34:D556-561. 1347495 16381931
225. Schmid CD Perier R Praz V Bucher P EPD in its twentieth year: Towards complete promoter coverage of selected model organisms Nucleic Acids Res 2006, 34:D82-85. 1347508 16381980
226. Odom DT Zizlsperger N Gordon DB Bell GW Rinaldi NJ Murray HL Volkert TL Schreiber J Rolfe PA Gifford DK Fraenkel E Bell GI Young RA Control of Pancreas and Liver Gene Expression by HNF Transcription Factors Science 2004, 303:1378-1381. 14988562
227. Zhang X Odom DT Koo S-H Conkright MD Canettieri G Best J Chen H Jenner R Herbolsheimer E Jacobsen E Kadam S Ecker JR Emerson B Hogenesch JB Unterman T Young RA Montminy M Genome-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues Proc Natl Acad Sci USA 2005, 102:4459-4464. 555478 15753290
228. Kim J Bhinge A Morgan X Iyer V Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment Nature Methods 2005, 2:47-53. 15782160
229. Wei C-L Wu Q Vega VB Chiu KP Ng P Zhang T Shahab A Yong HC Fu Y Weng Z A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome Cell 2006, 124:207-219. 16413492
230. Xuan Z Zhao F Wang J Chen G Zhang M Genome-wide promoter extraction and analysis in human, mouse, and rat Genome Biology 2005, 6:R72. 1273639 16086854
231. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University and National Center for Biotechnology Information, NLo Medicine Online Mendelian Inheritance in Man, OMIM (TM) 1998, 2006.
232. Meuller R The Denys-Drash syndrome Journal of Medical Genetics 1994, 31:471-477. 1049926 8071974